Co-Diagnostics, Inc.
CODX
Positions held
Your positionsCODX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $7.61M | Enterprise value | $4.96M | Trailing P/E | — | Forward P/E | -1.31 |
| PEG | — | Price / book | 0.42 | Beta | 2.90 | Dividend yield | 0.00% |
| Revenue growth | 2.0% | Earnings growth | — | Gross margin | 43.5% | Operating margin | -37.3% |
| Profit margin | 0.0% | ROE | -1.7% | ROA | -59.6% | Debt / equity | 0.14 |
| Current ratio | 1.81 | Free cash flow | -$17.49M | Analyst recommendation | none | Mean target | $4.00 |
| 52w high | $46.50 | 52w low | $0.91 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.2M | $0.1M | $0.3M | $0.1M | $0.2M | — |
| Op margin | -3732.5% | -6309.1% | -2902.3% | -4824.5% | -4946.1% | — |
| Net income | -$6.3M | -$9.1M | -$25.7M | -$5.9M | -$7.7M | — |
| Gross margin | 72.7% | -32.8% | 46.0% | 81.9% | 80.3% | — |
| Gross profit | $0.1M | -$0.0M | $0.1M | $0.1M | $0.1M | — |
| Operating income | -$6.2M | -$9.2M | -$7.7M | -$7.0M | -$8.1M | — |
- Revenue +14% vs prior quarter ($0.2M vs $0.1M).
- Gross margin 72.7% (was -32.8% prior quarter).
- Operating margin expanded to -3732.5%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.6M | $3.9M | $6.8M | $34.2M |
| Op margin | -5025.5% | -1023.7% | -626.9% | -33.9% |
| Net income | -$46.9M | -$37.6M | -$35.3M | -$14.2M |
| Gross margin | 64.3% | 74.5% | 38.6% | 84.0% |
| Gross profit | $0.4M | $2.9M | $2.6M | $28.7M |
| Operating income | -$31.3M | -$40.1M | -$42.7M | -$11.6M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe
2026-10-07 · Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease
2026-09-23 · Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week
2026-09-21 · Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation
2026-09-17 · Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026
2026-09-15 · Co-Diagnostics to Hold Press Conference
2026-09-03 · Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
2026-09-01 · Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
2026-08-20 · Co-Dx (CODX) Q2 2026 Earnings Call Transcript
2026-08-18 · Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
Price (daily)
Full chart · RSI · MACD · patterns